Please assess the completion status of the following clinical trial:

Trial Title: Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women of child bearing potential must have a negative pregnancy test, cannot be breastfeeding and must be willing to use contraception~* Willing to provide written informed consent and to comply with study requirements~* On a stable diet for at least 4 weeks with no plans to significantly alter diet or weight over course of study~* Normal electrocardiogram (ECG) at Screening~* No abnormal finding of clinical relevance (other than NASH, suspected NASH in patients) at Screening that could adversely impact subject safety during the study or adversely impact study results.~Exclusion Criteria:~* Clinically significant health concerns (other than NASH, suspected NASH in patients)~* Human immunodeficiency virus (HIV) infection, seropositive for Hepatitis B Virus (HBV), seropositive for Hepatitis C Virus (HCV)~* Uncontrolled hypertension~* Excessive use of alcohol within three months prior to Screening~* Use of illicit drugs within 1 year prior to Screening, or positive urine drug screen at Screening~* Use of an investigational agent or device within 30 days prior to dosing or current participation in an investigational study~NOTE: additional inclusion/exclusion criteria may apply, per protocol~-~-

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- ARO-HSD (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).